S evere brain injury, generally defined as head trauma associated with a Glasgow Coma Score (GCS) of Յ8 (1, 2) , is a challenging problem in critical care medicine. In contrast to many other areas of intensive care, brain injury often involves young individuals, and the outcome is highly dependent on the quality of the management (3) . As the brain is encased in a rigid skull, any increase in the size of its components (such as parenchymal swelling due to edema) will result in intracranial hypertension. There are many expansive intracranial processes that may result in intracranial hypertension, like intracranial hemorrhage, brain tumor, meningo-encephalitis, and severe metabolic derangements, such as hepatic encephalopathy or rapid electrolyte changes, so that some of the recommendations included in this article may apply to other disease states; however, we will focus this discussion on the management of brain injury.
PATHOPHYSIOLOGY
To understand the management of severe brain injury, it is important to review some of the basic underlying pathophysiologic mechanisms. After the initiating primary brain injury, edema formation is common and is classically considered as both vasogenic and cytotoxic. Vasogenic edema is secondary to a defect in the blood-brain barrier, resulting in permeability alterations with extravasation of fluid. Cytotoxic edema is believed to occur as the result of a massive increase in osmolality with breakdown of cellular structures and loss of the cell's ability to regulate its ionic gradients (4) .
As the cranial vault is a rigid structure, edema and hemorrhage force the intracranial pressure (ICP) to increase sharply. Various mechanisms exist to try and compensate for the increased ICP, including shunting of cerebrospinal fluid (CSF) to the spinal subarachnoid space, increasing CSF absorption, decreasing CSF production, and shunting venous blood out of the skull. However, once these compensatory mechanisms can no longer control ICP, it will increase, causing intracranial hypertension, which by reducing cerebral perfusion pressure (CPP), can cause cerebral ischemia. Further cerebral edema occurs, and the cycle continues with resultant irreversible neurologic damage. Importantly, recent studies have increasingly suggested that mitochondrial failure may play a crucial role in some of the above-mentioned processes and, hence, in the development and propagation of brain damage after severe traumatic brain injury (5, 6) .
Increased ICP may displace the brain, with herniation from areas of higher to lower pressure. Various herniation syndromes can occur, the most common clinically significant being uncal herniation, central transtentorial herniation, and infratentorial herniation, all ultimately resulting in brainstem compression with bradycardia, arterial hypertension, and respiratory irregularity followed by apnea.
METHODS OF EVALUATION
Clinical Neurologic Evaluation. A good clinical evaluation is essential in the assessment of the patient with severe brain injury. Clinical evaluation is largely based on repeated evaluation of the GCS and pupil size. Once the patient is intubated, the verbal component of the GCS may be omitted because the patient cannot speak, and the score is followed by the letter T. Some clinicians prefer to use the APACHE II (7) recommendations, in which a score of 1 is given if it is assumed that there would be no verbal response, a score of 5 if a normal verbal response is assumed, and a score of 3 if the verbal response is questionable. There is a reasonably good correlation between the severity of coma and the risk of intracranial hypertension, and the GCS has become widely accepted as a simple means of proving an estimate of outcome. Examination of the fundus is not reliable for identifying intracranial hypertension, especially in acute conditions, as the signs of edema occur late.
Imaging Techniques. The imaging evaluation of the patient with severe brain injury usually begins with a cerebral computed tomographic (CT) scan as an emergency procedure (8, 9):
• To identify intracranial lesions that may need surgical correction.
• To identify CSF obstruction (hydrocephalus).
• To appreciate the severity of cerebral edema or the presence of brain shift.
• To evaluate prognosis.
Marshall et al. (10) developed a now widely used system that classifies head injuries according to the changes seen on CT scan, defining four categories of injury (diffuse injury I-IV).
• In diffuse injury I, there is no evidence of intracranial pathology on CT scan.
• In diffuse injury II, cisterns are present, and there is a midline shift of 0 -5 mm. In addition, no high-density or mixed-density lesions (contusions) of Ͼ25 mL in volume are present.
• In diffuse injury III, there is a midline shift of 0 -5 mm, with partial compression or absence of the basal cisterns.
No high-or mixed-density lesions with a volume Ͼ25 mL are present.
• In diffuse injury IV, there is midline shift Ͼ5 mm, with compression or absence of the basal cisterns, and no lesions of high or mixed density of Ͼ25 mL.
Magnetic resonance imaging is increasingly used to better appreciate the type of cerebral lesions, including posterior fossa lesions (9) .
ICP Monitoring. As a general rule, ICP monitoring is initiated for patients with a GCS of Ͻ8, but the CT scan results (degree of edema, visualization of the cisterns, temporal lobe contusion, obliteration of the third ventricle) may influence the decision to monitor ICP. In patients with normal CT scans, ICP monitoring should be considered in those with two or more of the following: age of Ͼ40 yrs, unilateral or bilateral motor posturing, or a systolic blood pressure of Ͻ90 mm Hg (11) . The need for sedation may also reduce the decision threshold, as repeated neurologic evaluation will be more difficult.
Intraventricular catheter placement remains the standard method of monitoring ICP (12) . Although there are risks of misplacement, local bleeding, obstruction, and especially infection, intraventricular catheter placement also allows withdrawal of CSF, so diagnosis and treatment can be conducted at the same time. An alternative technique is a parenchymal catheter with fiberoptic or straingauge catheter tip transducer; their introduction is easy, but they are relatively expensive and drift of the catheter can be a problem. Epidural devices (fluidcoupled or pneumatic) and subarachnoid bolts are simple and carry less infectious risk, but they are usually less reliable and are prone to artifacts (12) . The use of antibiotic prophylaxis during placement of intracerebral monitoring devices is controversial. There are no randomized, controlled trial data to support or refute their use, although a retrospective study suggested that antibiotic prophylaxis has no effect on rates of infection (13) , and concerns remain regarding the risks of encouraging the development of antibiotic resistance (14) . The normal ICP is Ͻ15 mm Hg.
Jugular Venous Oxygen Saturation Monitoring. In severe cases, monitoring of the jugular venous oxygen saturation (SjO 2 ) by insertion of a catheter in the jugular bulb may provide additional useful information and help guide therapy (15) . The normal SjO 2 is generally slightly lower than the mixed venous oxygen saturation (i.e., around 65%). An SjO 2 of Ͻ60% indicates an inadequate cerebral blood flow (CBF) in relation to the oxygen requirements of the brain, and SjO 2 monitoring thus provides useful information on global cerebral oxygenation (16) . In conditions of low SjO 2 , one should explore whether an increase in mean arterial pressure (MAP) and CPP with fluids or vasopressor agents results in an increase in SjO 2 , although other causes of a reduced SjO 2 , including hypotension, hypoxia, hypocarbia, and elevated ICP, should also be considered. Importantly, hyperventilation, even if moderate, can frequently result in harmful local reductions of cerebral perfusion that cannot be detected by assessing SjO 2 , and hyperventilation should, therefore, be used with caution (16 The catheter is then perfused with a crystalloid solution (e.g., Ringer's) at low flow rates (0.1-2.0 L/min), and substances can diffuse from the extracellular fluid into the perfusate. This dialysate is then collected and analyzed to determine local levels of the substance(s) of interest (17, 18) . The data obtained with these techniques obviously depend on the location of the probe or the catheter, and they remain largely experimental at the present time.
Evoked Potentials. Evoked potentials, the electrical signals generated by the nervous system in response to sensory stimuli, are increasingly used to evaluate the severity of the neurologic damage in severe brain injury and to evaluate prognosis (see below) (19) . Median nerve evoked potentials, the most commonly used in this situation, are elicited by applying short external electrical stimuli to the median nerve at the wrist. The responses are recorded with superficial electroencephalogram electrodes above the contralateral sensory cortical field. The evoked potentials are separated from other electroencephalographic signals by computer-assisted averaging.
MANAGEMENT OF INTRACRANIAL HYPERTENSION

Underlying Principles
There are two important concepts underlying the management of intracranial hypertension. The first (the Monro-Kellie principle) is that the volume in the rigid skull is equal to the sum of the brain (almost 90% of the total), the CSF, and the blood and is altered by pathologic processes that increase the normal quantities of these components (e.g., hydrocephalus) or add new components (e.g., tumor). None of these components is really compressible, so that if one increases in size, the others must make room. Reducing intracranial hypertension can therefore, in principle, be achieved by reducing the space occupied by any of the four components:
• Reduce brain size: mannitol or other hypertonic substances.
• Reduce CSF: drainage.
• Reduce blood by inducing hyperventilation to induce vasoconstriction.
• Surgical removal of a pathologic process (tumor, hematoma).
Alternatively, one may open the skull to allow expansion of the structures (decompressive craniectomy).
The second concept (Rosner's conjecture) is that of secondary brain lesions secondary to cerebral ischemia as a consequence of systemic or cerebral factors. Deleterious systemic factors include arterial hypotension, hypoxemia, fever, hyperglycemia, and hypothermia. Cerebral factors include elevated ICP, lowered CPP, edema, space-occupying lesions, and seizures. All these abnormalities must be prevented or corrected.
Early Resuscitation
As always, early resuscitation should be based on the VIP (ventilate, infuse, pump) rule (20) .
Ventilate. The airway must be secured, using mechanical ventilation if necessary. Hypoxemia clearly worsens outcomes, and oxygen administration should be generous to maintain an SpO 2 of Ն95% at all times. There should be a low threshold for endotracheal intubation and as a matter of practice in patients with a GCS of Յ8.
There is no place for routine use of hyperventilation in patients with intracranial hypertension (see below) as it may decrease CBF and thereby worsen ischemic lesions (21) (22) (23) . Using microdialysis studies, Marion et al. (22) demonstrated that even brief periods of hyperventilation may induce some degree of cerebral ischemia. Studies have shown that in the early phase of severe brain injury, the CBF is already lower than in healthy individuals (24). PaCO 2 should be maintained at around 35 mm Hg (25). Hyperventilation should be reserved for cases with cerebral herniation (as manifest by a definitive decrease in consciousness, motor posturing, papillary dilation), when reduction in cerebral flow is considered as the priority to avoid an excessive increase in ICP.
Infuse. As a rule, arterial hypotension should be attributed to hypovolemia and should be corrected with fluid administration and control of the reason for the hypovolemia. In polytrauma, two largebore intravenous cannulae will be necessary. Either Ringer's lactate or normal saline are appropriate first-line fluids, but hypertonic saline may have a role (see below).
Pump. Hypoxemia and hypotension are the clinician's worst enemies during resuscitation of severe head trauma (26 -28). If cerebral trauma is severe, the systolic arterial pressure should be kept at Ͼ120 mm Hg (MAP of Ͼ90 mm Hg) (29). Combined inotropes/vasopressors such as dopamine or norepinephrine may be required to sustain arterial pressure in hypotension persisting despite fluid administration, although these should be used with caution, as their vasoconstriction effects potentially may impair local CBF, despite improving CPP (30). Norepinephrine seems to be the vasopressor of choice in these conditions (31-33).
Other Facets. Another facet to consider in early resuscitation is positioning. The head should be routinely elevated at 30 degrees (34 -36) to improve jugular venous return and decrease ICP. Further head elevation may result in a decrease in CPP and CBF (37). In severe arterial hypotension, priority should be given to CPP and CBF, and the patient should be kept flat.
Analgesia-sedation must also be considered, as pain must be adequately controlled. It is unacceptable to allow pain on the argument that analgesic medications may prevent a reliable neurologic evaluation. There is no real preference for one analgesic agent over another; the key factor is that arterial hypotension secondary to excessive doses of a sedative/ analgesic should be avoided and is more likely to occur in patients with underlying hypovolemia. Ketamine is best avoided as it may increase ICP, although the combinations of ketamine-midazolam or ketamine-sufentanil have recently been shown to be comparable in maintaining ICP and CPP in patients with severe head injury receiving mechanical ventilation (38). Etomidate is a safe choice to facilitate endotracheal intubation. Morphine or fentanyl are appropriate analgesics, observing the patient carefully for development of hypercapnia or hypotension. Sedative agents should be used if the patient is agitated. Propofol may be the preferred sedating agent based on its short duration of action, facilitating serial neurologic evaluations. Propofol-induced hypotension may occur, and it should be titrated carefully (39). The use of muscle relaxants should be avoided when possible but may be required when sudden unexpected cough or Valsalva maneuver puts the patient at risk for acute severe increases in ICP.
A final consideration is surgical management, of potential great importance, such as drainage of extradural or subdural hematomas, but it will not be considered here.
CONTROL OF ELEVATED ICP
The control of elevated ICP can be considered in three treatment steps, moving from one step to the next only if ICP remains uncontrolled (Fig. 1) .
First
Step. If ICP is Ͼ20 mm Hg, initially slight hyperventilation or at least avoidance of hypercapnia should be used, with a target PaCO 2 of around 35 mm Hg. The reduction in PaCO 2 associated with hyperventilation increases the pH of the CSF, which produces arterial vasoconstriction, in turn leading to an increase in cerebral vascular resistance and diminished CBF, cerebral blood volume, and ICP. If a ventricular drainage system is available, CSF should be drained when the ICP increases above threshold values of 15 to 20 mm Hg (40).
Second
Step. In the second step, mannitol (0.25 to 0.5 g/kg) or hypertonic saline (2 mL/kg body weight of 7.5% saline, approximately 480 mosm/70 kg body weight) is indicated. At present, there is no reason to prefer one over the other; in both cases, it is better to use intermittent boluses instead of a continuous infusion (41), and the plasma osmolarity should not exceed 32O mOsm/kg because there is an increased risk of renal failure (41). Mannitol acts by decreasing blood viscosity and expanding intravascular volume, thus increasing CBF (42, 43). Mannitol may accumulate in the brain, particularly in injured areas, with successive doses (44), possibly leading to a rebound effect when it is discontinued. Recent randomized, controlled trials (45) have suggested that early use of high-dose mannitol (1.4 g/kg) may be more effective than lowerdose regimens in controlling intracranial hypertension and improving outcomes in certain groups of comatose patients with severe head trauma, but further study is needed to define those patients who may best benefit from this approach.
Hypertonic saline decreases ICP without adversely affecting hemodynamic status (46, 47), and may have beneficial effects on excitatory neurotransmitters and on the immune system (48). In a recent randomized comparison of mannitol (20%) and hypertonic saline (7.5%) in 20 patients with head trauma, persistent coma, and intracranial hypertension resistant to standard modes of therapy, hypertonic saline was more effective at reducing intracranial hypertension (49). However, larger studies are needed to confirm or refute these findings.
Hyperventilation may be used (by increasing minute ventilation) to maintain PaCO 2 initially around 30 -35 mm Hg (in more severe cases, 28 -30 mm Hg); however, decreasing PaCO 2 to Ͻ25 mm Hg is potentially dangerous due to decreased CBF and the potential risk of ischemia. Hyperventilation may be used more aggressively to control ICP in head-injured patients, provided it is performed in conjunction with monitoring of SjO 2 (50).
Third
Step. If ICP remains high, there are two more options that can be used alone or in combination: barbiturates and decompressive craniectomy.
There are no randomized controlled trials assessing the effects of barbiturate therapy on outcome, but the syllogism is as follows: 1) intracranial hypertension is associated with a poor prognosis, especially if CPP cannot be maintained; 2) barbiturate therapy does decrease ICP (51) by decreasing the cerebral metabolic rate for oxygen and, consequently (due to coupling), CBF and cerebral blood volume, and barbiturates may also limit free-radical-mediated cell injury; 3) hence, it is logical to assume that barbiturate therapy would likely improve outcome. Although early randomized studies suggested an increased mortality in patients treated initially with pentobarbital as compared with those initially given mannitol (52), barbiturate coma can successfully lower ICP in some patients who are refractory to all other therapies aimed at lowering ICP (53-55).
If used, this treatment should include barbiturates with relatively short durations of action (i.e., thiopental or pentobarbital). Thiopental is administered as a loading dose of 5-10 mg/kg, followed by a continuous infusion of 3-5 mg·kg
. Pentobarbital is administered as a loading dose of 10 mg/kg over 30 mins, followed by 5 mg/kg every hour for three doses. Then, a maintenance dose of 1-2 mg/kg per hour is used (56). Barbiturates can induce hypotension, and patients should be carefully monitored, with insertion of a pulmonary artery catheter useful in complex cases to better assess the relative needs of fluids and inotropic agents. The aim of the therapy is to induce a profound barbiturate-induced coma to the point at which clinically there is no response to stimuli, no cough, and burst suppression is seen if under electroencephalographic control (57). Blood levels should not be the primary target, and it may be more useful to assess the degree of barbiturate impregnation after the barbiturate administration has been discontinued.
Concerning the use of decompressive craniectomy, either unilaterally or bilaterally, although there are no randomized controlled trials, case reports and personal experiences have suggested that patients undergoing surgical decompression, especially when applied early enough, may have good outcomes (58 -60).
CONTROL OF CPP
CPP, the difference between MAP and ICP, should be maintained at a minimum of 60 mm Hg, although lower values may be tolerated in infants. If the ICP cannot be controlled and after adequate fluid resuscitation, the administration of vasopressors like dopamine or norepinephrine may be used to maintain CPP by increasing MAP above baseline. However, in the absence of cerebral ischemia, aggressive attempts to maintain CPP at Ͼ70 mm Hg with fluids and vasopressors should be avoided because of the risk of acute respiratory distress syndrome (61, 62).
The Lund group (63) has taken a contrasting view and recommends that that CPP be maintained at only Ͼ50 mm Hg and that edema be decreased by all means, including diuretics, allowing the MAP to remain relatively low. Whether this approach is superior remains controversial. Therapy should ideally be guided by measurements of SjO 2 or tissue PO 2 measurements (61). 
ADDITIONAL MEASURES
Seizures complicate up to 20% of cases of severe brain injury, so prophylaxis is advised, although it does not prevent the long-term occurrence of seizures (64 -66) . Hence, it is not recommended that antiseizure prophylaxis be prolonged beyond the first week after the injury (67) . Phenytoin is the most widely used agent, although some prefer carbamazepine. Valproate offers ease of administration, but clinical trials have not validated its use for this indication. One randomized trial comparing valproate with phenytoin suggested a possible increased mortality in the valproate-treated patients (68) .
Arterial hypertension may occur, and if severe, it may carry the risk of worsening the edematous lesions by excessive intravascular pressures, especially if autoregulation is altered. It is typically the result of sympathetic hyperactivity resulting in so-called storming, a condition characterized by various symptoms including alterations in level of consciousness, increased posturing, dystonia, hypertension, hyperthermia, tachycardia, tachypnea, diaphoresis, and agitation. The hypertension should be treated only when severe, typically when MAP is Ͼ120 mm Hg. If pharmacologic intervention is needed, beta-blocking agents (if not contraindicated due to bradycardia, poor left ventricular function, or risk for bronchospasm) are preferred as the initial choice of therapy as they do not increase ICP. This is a potential problem with vasodilators such as nitroprusside or hydralazine. However, the optimal management remains undefined (69) .
Nutritional support should be started without delay, and certainly by day 7 (70), as catabolism starts early. Enteral nutrition is preferred. Head-injured patients have increased caloric and protein requirements, and these can be calculated using the Clifton equation, particularly in comatose patients (71) . A full caloric load of 25 kcal/kg is usually well tolerated.
Complications should be prevented and treated. Sepsis is a common complication and should be managed appropriately. Stress ulcer prophylaxis should be systematically introduced. Prevention of thromboembolic complications is also important. Heparin administration is usually contraindicated in the early course of the trauma patient, although a recent retrospective study noted no difference in bleeding events between patients administered heparin within 72 hrs of severe head injury and those who did not receive it until 3 days after the injury (72) . However, as the rates of thromboembolic events were also similar, there may be no benefit in giving prophylactic heparin earlier than 3 days after injury. Further prospective study is needed to help resolve this issue. Antithrombotic stockings or intermittent calf compression may be useful.
Both hyponatremia and hypernatremia may occur. Hyponatremia is usually due to the syndrome of inappropriate antidiuretic hormone secretion. Although fluid depletion can be associated with poorer outcomes in patients with head trauma (73) , if syndrome of inappropriate antidiuretic hormone secretion is diagnosed, moderate fluid restriction should be applied. If the Na concentration falls to Ͻ130 mEq/L, the administration of urea may be effective (74, 75) . Rarely, intravenous hypertonic saline may be used, but excessively rapid correction of the hyponatremia carries the risk of causing osmotic central nervous system demyelination, which can have disastrous consequences. Hypernatremia can also occur as a result of mannitol infusion or as part of diabetes insipidus.
Hyperglycemia may have harmful effects on cerebral function. Unless the patient has known risks for hypoglycemia, glucose-containing solutions are avoided during the early resuscitation phase to minimize the risks of hyperglycemia. Insulin administration may be needed to maintain blood sugar of Ͻ150 mg/dL (76) . Hypoglycemia is also detrimental and should be corrected quickly if it occurs.
Fever (core temperature of Ͼ38°C) should be aggressively treated as it increases cellular metabolism and vasodilation (77) . Antipyretic agents and cooling blankets may be used to effect cooling. Additional use of intravascular cooling techniques may improve fever reduction (78) .
PLACE FOR HYPOTHERMIA?
Hypothermia can reduce cerebral metabolism and brain volume. Hypothermia does have risks, including infections due to increased immunity. Although preclinical and smaller clinical studies suggested possible benefit (79 -82) , a multiple center trial (National Acute Brain Injury Study) involving 392 adult patients with closed head trauma could not demonstrate a beneficial effect (83) (84) . In addition, a recent meta-analysis suggests that, although no difference in mortality rates was noted in unselected brain trauma patients, iatrogenic hypothermia may confer a marginal benefit in neurologic outcome, particularly in patients with elevated ICP refractory to conventional manipulations (85) . The question remains as to whether hypothermia may be beneficial in certain patient groups.
UNPROVEN THERAPEUTIC MEASURES
Corticosteroids. Steroids have been tested in small clinical trials and have not been shown to improve outcomes from traumatic brain injury. In addition, metaanalyses of trials of steroids in head trauma support no overall benefit (86, 87) . A recent randomized, placebocontrolled trial (the CRASH trial) that included 10,008 patients with head injury found no reduction in 2-wk mortality in patients treated with steroids (88) . Until such time as these results are available, steroid use in patients with head trauma is not currently recommended (89) .
Experimental Therapies. Various other therapies, including glutamate antagonists (90), free-radical scavengers (91) , and calcium antagonists, have been studied as potential therapies to improve outcome in severe brain injury, so far without success (92) . Dexanabinol, a synthetic, nonpsychotropic cannabinoid, is a noncompetitive N-methyl-D-aspartate receptor inhibitor that has been shown to scavenge hydroxyl and peroxyl radicals (93) and to inhibit tumor necrosis factor production in experimental traumatic brain injury (94) . In a randomized, placebo-controlled, phase II clinical trial in 67 patients with severe head injury, Knoller et al. (95) showed that patients treated with one single dose of dexanabinol had a significant improvement in arterial hypotension, ICP, and CPP and a trend toward a better neurologic outcome. The results of a recently completed multinational, randomized, controlled trial are eagerly awaited, and this may be a promising drug for the future.
PROGNOSIS
The prognosis of the patient with severe brain injury is difficult to establish, and one should leave considerable place for uncertainty. Clinical evaluation in combination with CT scanning remains the best way to evaluate the severity and the outcome. Magnetic resonance imaging better defines anatomic lesions, especially in the brainstem. Median somatosensory evoked potentials can supplement and enhance neurologic examination findings and are a useful early guide to outcome. Bilateral absence of cortical evoked potentials correlates strongly with death or persistent vegetative state in severe brain trauma (96 -98) .
CONCLUSION
Severe brain injury can result in permanent neurologic disability, but outcomes can also be surprisingly good, especially in younger patients treated aggressively to reduce ICP and optimize CPP. The approach to severe brain injury is complex and requires a coordinated, stepwise approach including clinical assessment, imaging, monitoring, and control of ICP while optimizing CPP. With improved understanding of the pathophysiology underlying brain injury, effective new diagnostic, prognostic, monitoring, and treatment modalities will become available and will likely need to be incorporated into current management strategies. Effect 
